7-Ketocholesterol-induced oxidative stress impairs insulin secretion in pancreatic β-cells
Acta Diabetologica · 03.09.2026 · 63 (12) · 2135-2146
DOI: 10.1007/s00592-026-02781-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 03.09.2026. Verfasst von Wenjing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qinchun Road, Hangzhou, 310016,…. Hauptthemen laut MEDLINE: Ketocholesterols, Oxidative Stress, Insulin-Secreting Cells, Insulin Secretion. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: Glucolipotoxicity-induced β-cell dysfunction is a key factor in the pathogenesis of type 2 diabetes (T2D). While cholesterol is known to contribute to this dysfunction, the specific role of its major oxidation product, 7-ketocholesterol, remains unclear. METHODS: We quantified serum 7-ketocholesterol levels using UPLC-MS in a cohort comprising individuals with T2D and normal glucose tolerance (NGT). Using INS-1 cells and primary islets, we investigated the effects of 7-ketocholesterol on β-cell function (including glucose-stimulated insulin secretion [GSIS], perfusion and calcium dynamics) and the underlying mechanisms related to oxidative stress (reactive oxygen species [ROS], mitochondrial membrane potential [MMP], ATP) and gene/protein expression. The antioxidant N-Acetyl-L-cysteine (NAC) was employed to rescue the observed dysfunction. RESULTS: Cohort analysis showed serum 7-ketocholesterol levels were significantly elevated in T2D patients compared to NGT controls (0.070 ± 0.035 vs. 0.051 ± 0.021 µmol/L), and this elevation correlated negatively with early-phase insulin secretion. In INS-1 cells and primary islets, 7-ketocholesterol exposure impaired GSIS and disrupted intracellular calcium signaling. Furthermore, 7-ketocholesterol induced marked oxidative stress, characterized by increased ROS production, loss of MMP, and reduced ATP levels. Mechanistically, 7-ketocholesterol promoted NRF2 nuclear translocation and upregulated the expression of antioxidant genes, including Gpx4 and Sod1. Critically, co-treatment with NAC attenuated 7-ketocholesterol-induced oxidative stress and restored insulin secretion and calcium signaling. CONCLUSION: Our findings suggest that elevated 7-ketocholesterol is associated with β-cell dysfunction in T2D patients and appears to impair insulin secretion by inducing oxidative stress in pancreatic β-cells, positioning 7-ketocholesterol as a potential contributor to diabetes progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qinchun Road, Hangzhou, 310016, China.
- Department of Endocrinology and Metabolism, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qinchun Road, Hangzhou, 310016, China. zjq8866@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Wu, J., Zhao, Y., Wu, N., Sun, S., He, S., Lin, X., & Zhou, J. (2026). 7-Ketocholesterol-induced oxidative stress impairs insulin secretion in pancreatic β-cells. Acta Diabetologica, 63(12), 2135-2146. https://doi.org/10.1007/s00592-026-02781-7
Vancouver
Zhang W, Wu J, Zhao Y, Wu N, Sun S, He S, et al. 7-Ketocholesterol-induced oxidative stress impairs insulin secretion in pancreatic β-cells. Acta Diabetologica. 2026;63(12):2135-2146. doi:10.1007/s00592-026-02781-7
BibTeX
@article{Zhang2026,
author = {Zhang, Wenjing and Wu, Jiahua and Zhao, Yuchen and Wu, Nan and Sun, Shuiya and He, Sunyue and Lin, Xihua and Zhou, Jiaqiang},
title = {7-Ketocholesterol-induced oxidative stress impairs insulin secretion in pancreatic β-cells},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {12},
pages = {2135--2146},
doi = {10.1007/s00592-026-02781-7}
}
EUVIMED